Invert Sugar Electrolyte Injection
Function and Efficacy
This product can provide patients with water, electrolytes and energy, and produce diuretic and metabolic alkalizing effects. The lactate contained in it is metabolized in the liver to produce glycogen, and with the participation of H, it eventually produces CO2 and water.
Ingredients
This product is a compound preparation, and its components per 500ml include: glucose 25g, fructose 25g, sodium chloride 0.73g, potassium chloride 0.93g, magnesium chloride 0.143g, sodium dihydrogen phosphate 0.375g, sodium lactate 1.40g, and the osmotic pressure is 726mOsmo/L.
| Name | Description | Content | CAS NO. | Manufacturer |
|---|---|---|---|---|
| GLUCOSEIngredients |
Providing energy to patients More |
58367-01-4 | 14 | |
| beta-D-FructopyranoseIngredients |
Providing energy to patients More |
7660-25-5 | 14 | |
| Sodium chlorideIngredients |
Provide electrolytes to patients More |
7647-14-5 | 42 | |
| Potassium chlorideIngredients |
Provide electrolytes to patients More |
7447-40-7 | 38 | |
| Magnesium chlorideIngredients |
Provide electrolytes to patients More |
7786-30-3 | 23 | |
| Sodium dihydrogen phosphateIngredients |
Provide electrolytes to patients More |
89140-32-9 | 9 | |
| Sodium lactateIngredients |
Metabolic alkalization: the lactate contained in it is metabolized in the liver to produce glycogen, which, with the participation of H, eventually produces CO2 and water. More |
312-85-6 | 0 |
Appearance
This product is a colorless to slightly yellow clear liquid.
Indication
Suitable for fluid rehydration therapy for patients who need non-oral replenishment of water, energy and electrolytes.
Usage and Dosage
Usage: intravenous drip, use under the guidance of a doctor. Dosage: The dosage depends on the condition. The dosage for adults is 250ml-1000ml each time. The drip rate should be lower than 0.5g/kg/hr (calculated as fructose). Adjust the dosage according to the patient's age, weight, clinical condition and laboratory test results.
Adverse Reactions
It is reported that this drug may cause allergic reactions such as flushing, urticaria, and fever. Large doses and rapid infusion may cause lactic acidosis and hyperuricemia. Long-term use alone may cause electrolyte disorders. There are literature reports that patients with liver disease developed lactic acidosis after infusion of fructose. If adverse reactions occur, the infusion should be terminated.
Precautions
Patients with hereditary fructose intolerance are prohibited from using this product, and patients with gout and hyperuricemia are prohibited from using this product. Warning: Be cautious when using this product in excess or improperly, so as not to cause life-threatening lactic acidosis. Patients with undiagnosed hereditary fructose intolerance may be at risk of death when using this product.
Special Population Medication
Precautions for children: This experiment has not been conducted and there is no reliable reference. Precautions for pregnancy and lactation: It is not clear whether the use of this product by pregnant women will harm the fetus or affect reproductive ability. This product can only be used in pregnant women when it is clearly needed. Precautions for the elderly: Due to the weakening of various body functions, the elderly should slow down the administration speed and reduce the dosage when using it.
Drug Interactions
When used with other drugs, pay attention to the incompatibility of drugs (such as macrolide antibiotics, alkaloids, sulfonamides) due to changes in Ph and ionic strength. Precipitation may occur when encountering calcium ions, and other additives may also be incompatible with this product. Precipitation may occur when mixed with drugs containing carbonate ions.
Storage
Keep in a cool place away from light. The validity period is tentatively 12 months.
Packaging Specification
500ml: 25g fructose, 25g glucose, 1.4000g sodium lactate, 0.7300g sodium chloride, 0.9300g potassium chloride, 0.1430g magnesium chloride, and 0.3750g sodium dihydrogen phosphate
Validity Period
Tentative 18 months
Manufacturer
YANGTZE River Pharmaceutical Group Shanghai HAI-NI Pharmaceutical Co., Ltd.
-
Founded in:
2001-01-08 -
Address:
No. 3999, Hunan Road, Zhoupu Town, Pudong New Area -
Tax NO.:
91310115132179436W -
Registered Funds:
110 million yuan -
Website:
-
Email: